Enliven Therapeutics (ELVN)'s 30-day implied volatility (IV30) was 48.2% at the close on November 10, 2026, up from 44.6% the day before, against a 52-week range of 41.5% to 154.3%. Its 20-day historical volatility was 47.6%.
Data as of November 10, 2026.